Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,710 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,126
Recruiting: 10,896
Ph III recruiting: 1,279
Growth YoY: +12.3%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,169)

clinicaltrialsPublishedShowing 1,101–1,150 of 3,109 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06915454	High-Resolution PET-CT Imaging for Surgical Margin Visualization	recruiting	N/A	50	Vanderbilt-Ingram Cancer CenterOTHER	1	May 8, 2026	clinicaltrials
NCT07243483	Study of the Relationship Between the Pharmacokinetics (PK) and Pharmacodynamics of Venetoclax in Patients With Acute Myeloblastic Leukemia(EUREKA-VEN)	recruiting	N/A	100	Centre Leon BerardOTHER	1	May 8, 2026